Holen Sie sich die Stockscreener-App
0.6025
4.20%
-0.0264
Handel nachbörslich:
.55
-0.0525
-8.71%
Schlusskurs vom Vortag:
$0.6289
Offen:
$0.641
24-Stunden-Volumen:
162.37K
Relative Volume:
0.09
Marktkapitalisierung:
$3.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-736.70K
KGV:
-60.25
EPS:
-0.01
Netto-Cashflow:
$-4.14M
1W Leistung:
-8.73%
1M Leistung:
-25.58%
6M Leistung:
-40.94%
1J Leistung:
-57.86%
1-Tages-Spanne:
$0.6025
$0.641
1-Wochen-Bereich:
$0.6025
$0.73
52-Wochen-Spanne:
$0.6025
$1.79
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Firmenname
Xortx Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.6025 | 3.64M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xortx Therapeutics Inc Aktie (XRTX) Neueste Nachrichten
Statistical indicators supporting XORTX Therapeutics Inc.’s strengthJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Can XORTX Therapeutics Inc. stock sustain revenue growthProduct Launch & Safe Entry Trade Signal Reports - newser.com
What data driven models say about XORTX Therapeutics Inc.’s futureWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollar2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Is XORTX Therapeutics Inc. stock entering bullish territoryIPO Watch & Target Return Focused Stock Picks - newser.com
Can XORTX Therapeutics Inc. stock attract ESG capital inflowsPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com
XORTX Therapeutics Completes $1.1 Million Direct Offering - MSN
Is XORTX Therapeutics Inc. forming a bottoming baseJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Is XORTX Therapeutics Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Trade Execution Plans - newser.com
Will XORTX Therapeutics Inc. stock see insider buyingJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com
Predicting XORTX Therapeutics Inc. trend using moving averages2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Will XORTX Therapeutics Inc. bounce back from current support2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Will XORTX Therapeutics Inc. stock gain from government policiesMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Order flow analysis tools used on XORTX Therapeutics Inc.Bull Run & Entry Point Confirmation Alerts - newser.com
Can XORTX Therapeutics Inc. stock reach $100 price targetMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock attractive for growth funds2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
Can XORTX Therapeutics Inc. (ANUA) stock beat analyst consensusJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
How to build a custom watchlist for XORTX Therapeutics Inc.Quarterly Trade Summary & Fast Entry High Yield Tips - newser.com
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
XORTX Therapeutics Inc Stock Analysis and ForecastAnalyst Downgrades & Get Tomorrow’s Winners Today With AI - earlytimes.in
Vectus Biosystems Advances Strategic Partnerships and Licensing Opportunities - TipRanks
XORTX Therapeutics files to sell up to 4.76M shares - MSN
[6-K] XORTX Therapeutics Inc. Current Report (Foreign Issuer) - Stock Titan
Will XORTX Therapeutics Inc. stock maintain momentum in 2025Insider Buying & Low Risk Entry Point Guides - newser.com
XORTX Therapeutics Secures $1.1 Million in Direct Offering - TipRanks
XORTX Therapeutics Brief: Closed US$1.1 Million Registered Direct Offering - MarketScreener
XORTX Announces Closing of US$1.1 Million Registered Direct Offering - The Manila Times
Finanzdaten der Xortx Therapeutics Inc-Aktie (XRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):